Status:
UNKNOWN
Evaluation of Prognostic Potentials of Gingival Crevicular Fluid E-cadherin and Total Antioxidant Capacity
Lead Sponsor:
Ali A Abdulkareem
Conditions:
Periodontitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Ability to anticipate the outcomes of periodontal therapy at baseline visit is crucial to outline and customize a treatment plan with predictable outcomes and cost-effectiveness. Presence of diverse r...
Detailed Description
Loss of attachment and formation of periodontal pockets are hallmarks of periodontitis. The treatment approach is either by nonsurgical or surgical periodontal therapy or a combination of both dependi...
Eligibility Criteria
Inclusion
- Systemically healthy adult patients (\> 18 years).
- Periodontitis (interdental clinical attachment loss (CAL) detectable at ≥2 non-adjacent teeth, or buccal/oral CAL of ≥3mm with pocketing of \>3mm is detectable at ≥2 teeth). All patients should exhibit generalized periodontitis with pockets of PPD = 4 to 6 mm of any stage, unstable, and grade A to C. Only maxillary teeth with single root will be included.
Exclusion
- Consumption of antibiotics or periodontal treatment 3-months prior to the study.
- Pregnancy and lactation.
- Smoker.
- History of systemic disease e.g., diabetes mellitus.
- Patients currently recruited in other trials.
- Patients not willing to consent.
- Periodontal pockets ≥ 7mm, active caries, endodontic problem.
- Multi-rooted teeth will be also considered as exclusion reasons.
Key Trial Info
Start Date :
February 15 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 25 2023
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05994885
Start Date
February 15 2023
End Date
December 25 2023
Last Update
August 16 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
College of Dentistry/ University of Baghdad
Baghdad, Iraq